Parkinson's disease-associated parkin colocalizes with Alzheimer's disease and multiple sclerosis brain lesions

Neurobiology of Disease

Volumn 36, Issue 3, 2009, Pages 445-452

  Witte, Maarten E ^a   Bol, John G J M ^a   Gerritsen, Wouter H ^a   Valk, Paul van der ^a   Drukarch, Benjamin ^a   Horssen, Jack van ^a   Wilhelmus, Micha M M ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Alzheimer's disease; Astrocytes; Multiple sclerosis; Oxidative stress

Indexed keywords

AMYLOID PROTEIN; FREE RADICAL; MESSENGER RNA; PARKIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; ASTROCYTE; ASTROCYTOMA CELL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MULTIPLE SCLEROSIS; NERVOUS SYSTEM INFLAMMATION; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SENILE PLAQUE; TISSUE DISTRIBUTION; UPREGULATION;

ADULT; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID; ASTROCYTES; BRAIN; CELL LINE, TUMOR; FEMALE; FREE RADICALS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; RNA, MESSENGER; SENILE PLAQUES; UBIQUITIN-PROTEIN LIGASES;

EID: 70350345827     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2009.08.009     Document Type: Article

References (55)

1. Abbas N., Lucking C.B., Ricard S., Durr A., Bonifati V., De M.G., Bouley S., Vaughan J.R., Gasser T., Marconi R., Broussolle E., Brefel-Courbon C., Harhangi B.S., Oostra B.A., Fabrizio E., Bohme G.A., Pradier L., Wood N.W., Filla A., Meco G., Denefle P., Agid Y., and Brice A. A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe. French Parkinson's Disease Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson's Disease. Hum. Mol. Genet. 8 (1999) 567-574
2. Blasko I., Veerhuis R., Stampfer-Kountchev M., Saurwein-Teissl M., Eikelenboom P., and Grubeck-Loebenstein B. Costimulatory effects of interferon-gamma and interleukin-1beta or tumor necrosis factor alpha on the synthesis of Abeta1-40 and Abeta1-42 by human astrocytes. Neurobiol. Dis. 7 (2000) 682-689
3. Burns M.P., Zhang L., Rebeck G.W., Querfurth H.W., and Moussa C.E. Parkin promotes intracellular A{beta}1-42 clearance. Hum. Mol. Genet. 18 (2009) 3206-3216
4. Choi P., Golts N., Snyder H., Chong M., Petrucelli L., Hardy J., Sparkman D., Cochran E., Lee J.M., and Wolozin B. Co-association of parkin and alpha-synuclein. NeuroReport 12 (2001) 2839-2843
5. Chung K.K., Thomas B., Li X., Pletnikova O., Troncoso J.C., Marsh L., Dawson V.L., and Dawson T.M. S-nitrosylation of parkin regulates ubiquitination and compromises parkin's protective function. Science 304 (2004) 1328-1331
6. Darios F., Corti O., Lucking C.B., Hampe C., Muriel M.P., Abbas N., Gu W.J., Hirsch E.C., Rooney T., Ruberg M., and Brice A. Parkin prevents mitochondrial swelling and cytochrome c release in mitochondria-dependent cell death. Hum. Mol. Genet. 12 (2003) 517-526
7. De Groot C.J., Bergers E., Kamphorst W., Ravid R., Polman C.H., Barkhof F., and van d.V. Post-mortem MRI-guided sampling of multiple sclerosis brain lesions: increased yield of active demyelinating and (p)reactive lesions. Brain 124 (2001) 1635-1645
8. de Vries H.E., Witte M., Hondius D., Rozemuller A.J., Drukarch B., Hoozemans J., and van H.J. Nrf2-induced antioxidant protection: a promising target to counteract ROS-mediated damage in neurodegenerative disease?. Free Radic. Biol. Med. 45 (2008) 1375-1383
9. Dong Y., and Benveniste E.N. Immune function of astrocytes. Glia 36 (2001) 180-190
10. Dumont M., Wille E., Stack C., Calingasan N.Y., Beal M.F., and Lin M.T. Reduction of oxidative stress, amyloid deposition, and memory deficit by manganese superoxide dismutase overexpression in a transgenic mouse model of Alzheimer's disease. FASEB J. 23 (2009) 2459-2466
11. Encinas J.M., Manganas L., and Enikolopov G. Nitric oxide and multiple sclerosis. Curr. Neurol. Neurosci. Rep. 5 (2005) 232-238
12. Franklin R.J., Gilson J.M., and Blakemore W.F. Local recruitment of remyelinating cells in the repair of demyelination in the central nervous system. J. Neurosci. Res. 50 (1997) 337-344
13. Furuta A., Price D.L., Pardo C.A., Troncoso J.C., Xu Z.S., Taniguchi N., and Martin L.J. Localization of superoxide dismutases in Alzheimer's disease and Down's syndrome neocortex and hippocampus. Am. J. Pathol. 146 (1995) 357-367
14. Garcia-Vallejo J.J., Van D.W., Van Het H.B., Van Die I., Engelse M.A., Van Hinsbergh V.W., and Gringhuis S.I. Activation of human endothelial cells by tumor necrosis factor-alpha results in profound changes in the expression of glycosylation-related genes. J. Cell Physiol. 206 (2006) 203-210
15. Gilgun-Sherki Y., Melamed E., and Offen D. The role of oxidative stress in the pathogenesis of multiple sclerosis: the need for effective antioxidant therapy. J. Neurol. 251 (2004) 261-268
16. Glenner G.G., and Wong C.W. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120 (1984) 885-890
17. Gu Z., Nakamura T., Yao D., Shi Z.Q., and Lipton S.A. Nitrosative and oxidative stress links dysfunctional ubiquitination to Parkinson's disease. Cell Death Differ. 12 (2005) 1202-1204
18. Hasegawa T., Treis A., Patenge N., Fiesel F.C., Springer W., and Kahle P.J. Parkin protects against tyrosinase-mediated dopamine neurotoxicity by suppressing stress-activated protein kinase pathways. J. Neurochem. 105 (2008) 1700-1715
19. Henn I.H., Bouman L., Schlehe J.S., Schlierf A., Schramm J.E., Wegener E., Nakaso K., Culmsee C., Berninger B., Krappmann D., Tatzelt J., and Winklhofer K.F. Parkin mediates neuroprotection through activation of IkappaB kinase/nuclear factor-kappaB signaling. J. Neurosci. 27 (2007) 1868-1878
20. Holscher C. Development of beta-amyloid-induced neurodegeneration in Alzheimer's disease and novel neuroprotective strategies. Rev. Neurosci. 16 (2005) 181-212
21. Imai Y., Soda M., and Takahashi R. Parkin suppresses unfolded protein stress-induced cell death through its E3 ubiquitin-protein ligase activity. J. Biol. Chem. 275 (2000) 35661-35664
22. Keller J.N., Hanni K.B., and Markesbery W.R. Impaired proteasome function in Alzheimer's disease. J. Neurochem. 75 (2000) 436-439
23. Kitada T., Asakawa S., Hattori N., Matsumine H., Yamamura Y., Minoshima S., Yokochi M., Mizuno Y., and Shimizu N. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392 (1998) 605-608
24. Kornek B., Storch M.K., Weissert R., Wallstroem E., Stefferl A., Olsson T., Linington C., Schmidbauer M., and Lassmann H. Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions. Am. J. Pathol. 157 (2000) 267-276
25. Ledesma M.D., Galvan C., Hellias B., Dotti C., and Jensen P.H. Astrocytic but not neuronal increased expression and redistribution of parkin during unfolded protein stress. J. Neurochem. 83 (2002) 1431-1440
26. Lee V.M., Balin B.J., Otvos Jr. L., and Trojanowski J.Q. A68: a major subunit of paired helical filaments and derivatized forms of normal Tau. Science 251 (1991) 675-678
27. Lipton S.A., Gu Z., and Nakamura T. Inflammatory mediators leading to protein misfolding and uncompetitive/fast off-rate drug therapy for neurodegenerative disorders. Int. Rev. Neurobiol. 82 (2007) 1-27
28. Mirra S.S., Heyman A., McKeel D., Sumi S.M., Crain B.J., Brownlee L.M., Vogel F.S., Hughes J.P., van B.G., and Berg L. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41 (1991) 479-486
29. Moreira P.I., Santos M.S., Oliveira C.R., Shenk J.C., Nunomura A., Smith M.A., Zhu X., and Perry G. Alzheimer disease and the role of free radicals in the pathogenesis of the disease. CNS. Neurol. Disord. Drug Targets 7 (2008) 3-10
30. Perry G., Friedman R., Shaw G., and Chau V. Ubiquitin is detected in neurofibrillary tangles and senile plaque neurites of Alzheimer disease brains. Proc. Natl. Acad. Sci. U. S. A. 84 (1987) 3033-3036
31. Power J.H., Asad S., Chataway T.K., Chegini F., Manavis J., Temlett J.A., Jensen P.H., Blumbergs P.C., and Gai W.P. Peroxiredoxin 6 in human brain: molecular forms, cellular distribution and association with Alzheimer's disease pathology. Acta Neuropathol. 115 (2008) 611-622
32. Rosen K.M., Veereshwarayya V., Moussa C.E., Fu Q., Goldberg M.S., Schlossmacher M.G., Shen J., and Querfurth H.W. Parkin protects against mitochondrial toxins and beta-amyloid accumulation in skeletal muscle cells. J. Biol. Chem. 281 (2006) 12809-12816
33. Schlossmacher M.G., Frosch M.P., Gai W.P., Medina M., Sharma N., Forno L., Ochiishi T., Shimura H., Sharon R., Hattori N., Langston J.W., Mizuno Y., Hyman B.T., Selkoe D.J., and Kosik K.S. Parkin localizes to the Lewy bodies of Parkinson disease and dementia with Lewy bodies. Am. J. Pathol. 160 (2002) 1655-1667
34. Schreibelt G., van H.J., van R.S., Dijkstra C.D., Drukarch B., and de Vries H.E. Therapeutic potential and biological role of endogenous antioxidant enzymes in multiple sclerosis pathology. Brain Res. Rev. 56 (2007) 322-330
35. Selkoe D.J. The molecular pathology of Alzheimer's disease. Neuron 6 (1991) 487-498
36. Shimura H., Hattori N., Kubo S., Yoshikawa M., Kitada T., Matsumine H., Asakawa S., Minoshima S., Yamamura Y., Shimizu N., and Mizuno Y. Immunohistochemical and subcellular localization of Parkin protein: absence of protein in autosomal recessive juvenile parkinsonism patients. Ann. Neurol. 45 (1999) 668-672
37. Shimura H., Hattori N., Kubo S., Mizuno Y., Asakawa S., Minoshima S., Shimizu N., Iwai K., Chiba T., Tanaka K., and Suzuki T. Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. Nat. Genet. 25 (2000) 302-305
38. Stichel C.C., Augustin M., Kuhn K., Zhu X.R., Engels P., Ullmer C., and Lubbert H. Parkin expression in the adult mouse brain. Eur. J. Neurosci. 12 (2000) 4181-4194
39. Tamo W., Imaizumi T., Tanji K., Yoshida H., Takanashi S., Wakabayashi K., Takahashi R., Hattori N., and Satoh K. Parkin is expressed in vascular endothelial cells. Neurosci. Lett. 419 (2007) 199-201
40. Tanaka K., Suzuki T., Chiba T., Shimura H., Hattori N., and Mizuno Y. Parkin is linked to the ubiquitin pathway. J. Mol. Med. 79 (2001) 482-494
41. Trapp B.D., and Nave K.A. Multiple sclerosis: an immune or neurodegenerative disorder?. Annu. Rev. Neurosci. 31 (2008) 247-269
42. Trapp B.D., Peterson J., Ransohoff R.M., Rudick R., Mork S., and Bo L. Axonal transection in the lesions of multiple sclerosis. N. Engl. J. Med. 338 (1998) 278-285
43. Van Der Valk P., and De Groot C.J. Staging of multiple sclerosis (MS) lesions: pathology of the time frame of MS. Neuropathol. Appl. Neurobiol. 26 (2000) 2-10
44. Van Horssen J., Vos C.M., Admiraal L., van Haastert E.S., Montagne L., van der Valk P., and de Vries H.E. Matrix metalloproteinase-19 is highly expressed in active multiple sclerosis lesions. Neuropathol. Appl. Neurobiol. 32 (2006) 585-593
45. Van Horssen J., Schreibelt G., Drexhage J., Hazes T., Dijkstra C.D., van der Valk P., and de Vries H.E. Severe oxidative damage in multiple sclerosis lesions coincides with enhanced antioxidant enzyme expression. Free Radic. Biol. Med. 45 (2008) 1729-1737
46. Wang C., Ko H.S., Thomas B., Tsang F., Chew K.C., Tay S.P., Ho M.W., Lim T.M., Soong T.W., Pletnikova O., Troncoso J., Dawson V.L., Dawson T.M., and Lim K.L. Stress-induced alterations in parkin solubility promote parkin aggregation and compromise parkin's protective function. Hum. Mol. Genet. 14 (2005) 3885-3897
47. Weller R.O., Massey A., Kuo Y.M., and Roher A.E. Cerebral amyloid angiopathy: accumulation of A beta in interstitial fluid drainage pathways in Alzheimer's disease. Ann. N. Y. Acad. Sci. 903 (2000) 110-117
48. Wilhelmus M.M., Otte-Holler I., Davis J., Van Nostrand W.E., de Waal R.M., and Verbeek M.M. Apolipoprotein E genotype regulates amyloid-beta cytotoxicity. J. Neurosci. 25 (2005) 3621-3627
49. Wilhelmus M.M., Otte-Holler I., Wesseling P., de Waal R.M., Boelens W.C., and Verbeek M.M. Specific association of small heat shock proteins with the pathological hallmarks of Alzheimer's disease brains. Neuropathol. Appl. Neurobiol. 32 (2006) 119-130
50. Wilhelmus M.M., Boelens W.C., Kox M., Maat-Schieman M.L., Veerhuis R., de Waal R.M., and Verbeek M.M. Small heat shock proteins associated with cerebral amyloid angiopathy of hereditary cerebral hemorrhage with amyloidosis (Dutch type) induce interleukin-6 secretion. Neurobiol. Aging 30 (2009) 229-240
51. Wilhelmus, M.M., Verhaar, R., Bol, J.G., van Dam, A.M., Hoozemans, J.J., Rozemuller, A.J., Drukarch, B., in press. Novel role of transglutaminase 1 in corpora amylacea formation? Neurobiol. Aging. doi:10.1016/j.neurobiolaging.2009.04.019.
52. Williams A., Piaton G., and Lubetzki C. Astrocytes-friends or foes in multiple sclerosis?. Glia 55 (2007) 1300-1312
53. Witte M.E., Bo L., Rodenburg R.J., Belien J.A., Musters R., Hazes T., Wintjes L.T., Smeitink J.A., Geurts J.J.G., de Vries H.E., Van Der Valk P., and Van Horssen J. Enhanced number and activity of mitochondria in multiple sclerosis lesions. J. Pathol. 219 (2009) 193-204
54. Xu J., Chen S., Ku G., Ahmed S.H., Xu J., Chen H., and Hsu C.Y. Amyloid beta peptide-induced cerebral endothelial cell death involves mitochondrial dysfunction and caspase activation. J. Cereb. Blood Flow Metab. 21 (2001) 702-710
55. Zarate-Lagunes M., Gu W.J., Blanchard V., Francois C., Muriel M.P., Mouatt-Prigent A., Bonici B., Parent A., Hartmann A., Yelnik J., Boehme G.A., Pradier L., Moussaoui S., Faucheux B., Raisman-Vozari R., Agid Y., Brice A., and Hirsch E.C. Parkin immunoreactivity in the brain of human and non-human primates: an immunohistochemical analysis in normal conditions and in Parkinsonian syndromes. J. Comp. Neurol. 432 (2001) 184-196